Clinical Drug Experience Knowledgebase

bifidobacterium animalis (1 trial)

ciprofol (1 trial)

dapagliflozin (farxiga) (1 trial)

deng zhan sheng mai (1 trial)

denosumab (prolia) (5 trials)

dexamethasone (1 trial)

etoposide (vepesid) (3 trials)

infliximab (remicade) (1 trial)

insulin aspart (Novolog) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

Lactobacillus acidophilus (1 trial)

mercaptopurine (purinethol) (1 trial)

metformin (glucophage) (3 trials)

naltrexone (revia) (1 trial)

piperacillin (pipracil) (1 trial)

propofol (diprivan) (1 trial)

ribavirin (virazole) (1 trial)

ruxolitinib (jakafi) (1 trial)

saxagliptin (onglyza) (1 trial)

somatropin (protropin) (1 trial)

streptokinase (streptase) (1 trial)

sulbactam (unasyn) (1 trial)

urea (1 trial)

urokinase (kinlytic) (1 trial)

vincristine (oncovin) (1 trial)

xingnaojing (2 trials)

xin te mie (1 trial)

zoledronic acid (zometa) (3 trials)

aclarubicin (1 trial)

capecitabine (xeloda) (3 trials)

carboplatin (paraplatin) (4 trials)

cisplatin (platinol) (4 trials)

clevidipine (cleviprex) (1 trial)

cytarabine (cytosar-u) (1 trial)

decitabine (dacogen) (3 trials)

dydrogesterone (gynorest) (1 trial)

Filgrastim (neupogen) (1 trial)

fulvestrant (faslodex) (1 trial)

gefitinib (iressa) (1 trial)

gimeracil (1 trial)

lapatinib (tykerb) (3 trials)

omacetaxine (synribo) (1 trial)

oteracil (1 trial)

s-1 (1 trial)

Tafolecimab (2 trials)

tegafur (1 trial)

vinorelbine (navelbine) (2 trials)

4scar123 (1 trial)

4scar19 (2 trials)

4scar20 (1 trial)

4scar22 (1 trial)

4scar-276 (1 trial)

4scar79b (1 trial)

4scar-gd2 (1 trial)

4scar-psma (2 trials)

allisartan isoproxil (1 trial)

allogeneic cd19 car-t cells (2 trials)

Antigen Peptide-specific DC-CTL Cells (1 trial)

autologous CD276 car-T cells (1 trial)

autologous cd34+ cells (1 trial)

autologous natural killer cells (2 trials)

bcma-pd1-cart cell (1 trial)

bevacizumab (avastin) (2 trials)

camrelizumab (1 trial)

cd19 car-t cells (4 trials)

cd20 car-t cells (1 trial)

cd22 car-t cells (1 trial)

cd44v6-specific car gene-engineered t cells (1 trial)

cetuximab (erbitux) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

epirubicin (ellence) (1 trial)

epoetin (Epogen) (1 trial)

gd2, psma and cd276 car-t cells (1 trial)

gemcitabine (gemzar) (2 trials)

multiple sarcoma-specific car-t cells (1 trial)

olmesartan (benicar) (1 trial)

paclitaxel (taxol) (1 trial)

prostaglandin (1 trial)

Raltitrexed (1 trial)

regorafenib (stivarga) (1 trial)

roxadustat (1 trial)

sacubitril (Entresto) (1 trial)

sintilimab (1 trial)

toripalimab (2 trials)

trastuzumab (herceptin) (1 trial)

umbilical cord mesenchymal stem cells (1 trial)

autologous dendritic cells loaded with autologous tumor lysate (1 trial)

beraprost (1 trial)

histrelin (supprelin) (1 trial)

hpv16 e7 peptide-pulsed autologous dcs (1 trial)

β-globin restored autologous hsc (1 trial)

anti-ny eso-1 tcr-transduced t cells (1 trial)

artemisia (1 trial)

autologous microbiome (1 trial)

benazepril (lotensin) (1 trial)

bovine colostrum (2 trials)

bupivacaine (Exparel) (1 trial)

carbetocin (Pabal) (1 trial)

carboprost tromethamine (hemabate) (1 trial)

car-cldn18.2 t-cells (1 trial)

cd7 car-t cell (1 trial)

febuxostat (uloric) (1 trial)

gardenia jasminoides ellis (1 trial)

gpc3 car-t cell (1 trial)

midazolam (versed) (1 trial)

oxytocin (syntocinon) (1 trial)

paeoniae radix (1 trial)

remimazolam (Byfavo) (1 trial)

rhizoma atractylodis macrocephalae (1 trial)

ropivacaine (naropin) (1 trial)

rubia cordifolia (1 trial)

salvia (1 trial)

sen miao san (1 trial)

sieyesbeckiaorientalis (1 trial)

valsartan (diovan) (1 trial)

whole blood (1 trial)